Company Filing History:
1 out of 79 
1 out of 816 
Years Active: 2021
Title: Fumiyasu Momose: Innovator in Cancer Therapeutics
Introduction
Fumiyasu Momose is a notable inventor based in Tsu, Japan. He has made significant contributions to the field of cancer therapeutics, particularly through his innovative research on exosomes and their role in treating cell-proliferative diseases. His work focuses on harnessing the power of cytotoxic T cells to develop effective therapeutic agents.
Latest Patents
Fumiyasu Momose holds a patent for a therapeutic agent associated with the suppression of proliferation and metastasis of tumors. This patent describes a method that utilizes exosomes released from cytotoxic T cells to target cancer stromal and mesenchymal cells. The therapeutic agents developed from this research are effective in treating cell-proliferative diseases by suppressing the proliferation of mesenchymal cells surrounding cancer cells, thereby isolating the cancer cells and preventing metastasis. This innovative approach offers new hope for patients suffering from various forms of cancer.
Career Highlights
Throughout his career, Fumiyasu Momose has been affiliated with prestigious institutions such as Mie University and Kyoto University. His research has garnered attention for its potential to revolutionize cancer treatment and improve patient outcomes. His dedication to advancing medical science is evident in his innovative approaches to tackling complex health issues.
Collaborations
Fumiyasu Momose has collaborated with esteemed colleagues, including Hiroshi Shiku and Naohiro Seo. These partnerships have contributed to the advancement of his research and the development of groundbreaking therapeutic agents.
Conclusion
Fumiyasu Momose's work in cancer therapeutics exemplifies the impact of innovative research on medical science. His patent for a therapeutic agent utilizing exosomes from cytotoxic T cells represents a significant advancement in the fight against cancer. Through his contributions, he continues to inspire future innovations in the field.